Additional Information and Where to Find It
Nuvelo has filed a registration statement on Form S-4, and a related proxy statement/prospectus/consent solicitation, in connection with the merger. Investors and security holders are urged to read the registration statement on Form S-4 and the related proxy statement/prospectus/consent solicitation because they contain important information about the merger transaction. Investors and security holders may obtain free copies of these documents and other documents filed with the SEC at the SEC's website at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by contacting Nuvelo Investor Relations at the email address: firstname.lastname@example.org or by phone at 650-517-8000.
In addition to the registration statement and related proxy
statement/prospectus/consent solicitation, Nuvelo files annual, quarterly and
special reports, proxy statements and other information with the SEC. You may
read and copy any reports, statements or other information filed by Nuvelo,
Inc. at the SEC public reference room at 100 F Street, N.E., Washington, D.C.
20549. Please call the SEC at 1-800-SEC-0330 for more information. Please call
the SEC at 1-800-SEC-0330 for further information on the public reference
room. Nuvelo, Inc.'s fili
|SOURCE Nuvelo, Inc.; ARCA biopharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved